The quality of Medicaid and Medicare data obtained from CMS and its contractors: Implications for pharmacoepidemiology

BMC Health Services Research

Volumn 17, Issue 1, 2017, Pages

  Leonard, Charles E ^a   Brensinger, Colleen M ^a   Nam, Young Hee ^a   Bilker, Warren B ^a   Barosso, Geralyn M ^b   Mangaali, Margaret J ^a   Hennessy, Sean ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Centers for Medicare and Medicaid Services (U.S.); Data accuracy; Databases as a topic; International Classification of Diseases; Medicaid; Medicare; Pharmacoepidemiology

Indexed keywords

AGED; FEMALE; GOVERNMENT; HOSPITALIZATION; HUMAN; INSURANCE; MALE; MEDICAID; MEDICARE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; STANDARDS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); FEMALE; HOSPITALIZATION; HUMANS; INSURANCE CLAIM REPORTING; MALE; MEDICAID; MEDICARE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; UNITED STATES;

EID: 85018803216     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/s12913-017-2247-7     Document Type: Article

References (33)

1. Hennessy S, Freeman CP, Cunningham F. US government claims databases. In: Strom BL, Kimmel SE, Hennessy S, editors. Pharmacoepidemiology. 5th ed. Chichester: Wiley-Blackwell; 2012. p. 209-23.
2. Crystal S, Akincigil A, Bilder S, Walkup JT. Studying prescription drug use and outcomes with Medicaid claims data: strengths, limitations, and strategies. Med Care. 2007;45(10 Supl 2):S58-65.
3. Ray WA. Policy and program analysis using administrative databases. Ann Intern Med. 1997;127(8 Pt 2):712-8.
4. Centers for Medicare & Medicaid Services. Frequently asked questions. FAQ2455. Available at: https://questions.cms.gov/faq.php?id=5005&faqId=2455. Accessed 21 Apr 2017.
5. Centers for Medicare & Medicaid Services. Details for title: Medicaid Analytic Extract production, enhancement, and data quality MAX-PDQ. Active Projects Report. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/ActiveProjectReports/Active-Projects-Reports-Items/CMS1187450.html. Accessed 21 Apr 2017.
6. Ruttner L, Borck R, Nysenbaum J, Williams S. Medicaid policy brief: guide to MAX data. Math Policy Res Brief. 2015;21:1-10.
7. West SL, Ritchey ME, Poole C. Validity of pharmacoepidemiologic drug and diagnosis data. In: Strom BL, Kimmel SE, Hennessy S, editors. Pharmacoepidemiology. 5th ed. Chichester: Wiley-Blackwell; 2012. p. 757-94.
8. Barosso G. Conducting research with Medicaid claims data videos. 2016. Available at: http://www.resdac.org/training/workshops/intro-medicaid/media/1. Accessed 21 Apr 2017.
9. Kaiser Family Foundation. Medicaid enrollment by gender. State Health Facts web site. 2015. Available at: http://kff.org/medicaid/state-indicator/medicaid-enrollment-by-gender/. Accessed 21 Apr 2017.
10. Research Data Assistance Center. RIF Medicare claims. RIF Medicare claims web site. 2016. Available at: http://www.resdac.org/cms-data/file-family/RIF-Medicare-Claims. Accessed 21 Apr 2017.
11. Hennessy S, Bilker WB, Weber A, Strom BL. Descriptive analyses of the integrity of a US medicaid claims database. Pharmacoepidemiol Drug Saf. 2003;12(2):103-11.
12. Moody G, Health Policy Institute of Ohio. Ohio Medicaid basics 2007. 2007:1-23. Available at: http://www.healthpolicyohio.org/wp-content/uploads/2014/02/medicaidbasics-2007.pdf. Accessed 21 Apr 2017.
13. The Center for Health Affairs. The evolution of Medicaid managed care in Ohio. 2007:1-12. Available at: https://neohospitals.org/FinanceAndReimbursement/DataResources. Accessed 21 Apr 2017.
14. Mathematica Policy Research. MSIS State Data Characteristics / Anomalies Report. 2015:1-364. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Computer-Data-and-Systems/MedicaidDataSourcesGenInfo/MAX-Validation-Reports.html. Accessed 21 Apr 2017.
15. Hennessy S, Leonard CE, Palumbo CM, Newcomb C, Bilker WB. Quality of Medicaid and Medicare data obtained through Centers for Medicare and Medicaid services (CMS). Med Care. 2007;45(12):1216-20.
16. The Henry J. Kaiser Family Foundation. Dual Eligibles. Dual Eligibles Tutorial web site. 2012. Available at: http://kff.org/interactive/dual-eligibles-tutorial/. Accessed 21 Apr 2017.
17. Byrne DD, Newcomb CW, Carbonari DM, Nezamzadeh MS, Leidl KB, Herlim M, Yang YX, Hennessy S, Kostman JR, Leonard MB, Localio R, Lo Re III V. Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007. Ann Epidemiol. 2014;24(6):418-23.
18. Palmsten K, Huybrechts KF, Kowal MK, Mogun H, Hernandez-Diaz S. Validity of maternal and infant outcomes within nationwide Medicaid data. Pharmacoepidemiol Drug Saf. 2014;23(6):646-55.
19. Cook EA, Schneider KM, Robinson J, Wilwert J, Chrischilles E, Pendergast J, Brooks J. Field methods in medical record abstraction: assessing the properties of comparative effectiveness estimates. BMC Health Serv Res. 2014;14:391.
20. Calderwood MS, Kleinman K, Bratzler DW, Ma A, Kaganov RE, Bruce CB, Balaconis EC, Canning C, Platt R, Huang SS, CDC Prevention Epicenters Program, Oklahoma Foundation for Medical Quality. Medicare claims can be used to identify US hospitals with higher rates of surgical site infection following vascular surgery. Med Care. 2014;52(10):918-25.
21. Calderwood MS, Kleinman K, Bratzler DW, Ma A, Bruce CB, Kaganov RE, Canning C, Platt R, Huang SS, Centers for Disease Control and Prevention Epicenters Program, Oklahoma Foundation for Medical Quality. Use of Medicare claims to identify US hospitals with a high rate of surgical site infection after hip arthroplasty. Infect Control Hosp Epidemiol. 2013;34(1):31-9.
22. Katz JN, Wright EA, Baron JA, Corbett KL, Nti AA, Malchau H, Wright J, Losina E. Predictive value of Medicare claims data for identifying revision of index hip replacement was modest. J Clin Epidemiol. 2011;64(5):543-6.
23. Hennessy S, Leonard CE, Freeman CP, Deo R, Newcomb C, Kimmel SE, Strom BL, Bilker WB. Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf. 2010;19(6):555-62.
24. Hennessy S, Leonard CE, Bilker WB. Researchers and HIPAA. Epidemiology. 2007;18(4):518.
25. Lo Re III V, Haynes K, Ming EE, Wood Ives J, Horne LN, Fortier K, Carbonari DM, Hennessy S, Cardillo S, Reese PP, Reddy KR, Margolis D, Apter A, Kimmel SE, Roy J, Freeman CP, Razzaghi H, Holick CN, Esposito DB, Van Staa TP, Bhullar H, Strom BL. Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies. Pharmacoepidemiol Drug Saf. 2012;21(11):1202-15.
26. Schelleman H, Bilker WB, Brensinger CM, Wan F, Yang YX, Hennessy S. Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. Am J Med. 2010;123(2):151-7.
27. Schelleman H, Bilker WB, Brensinger CM, Wan F, Hennessy S. Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide. Clin Pharmacol Ther. 2010;88(2):214-22.
28. Kahn MG, Raebel MA, Glanz JM, Riedlinger K, Steiner JF. A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care. 2012;50(Suppl):S21-29.
29. Brown JS, Kahn M, Toh S. Data quality assessment for comparative effectiveness research in distributed data networks. Med Care. 2013;51(8 Suppl 3):S22-29.
30. Baron JA, Lu-Yao G, Barrett J, McLerran D, Fisher ES. Internal validation of Medicare claims data. Epidemiology. 1994;5(5):541-4.
31. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol. 1989;129(4):837-49.
32. Al Kazzi ES, Hutfless S. Better big data. Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):873-6.
33. Cai L, Zhu Y. The challenges of data quality and data quality assessment in the big data era. Data Sci J. 2015;14:2.